The increasing demand for precise immunological study and therapeutic development has spurred significant advances in recombinant growth factor manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently generated using various expression platforms, including prokaryotic hosts, animal cell cultures, and baculo